Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
Funding Amount
Varies
Deadline
June 16, 2028
627 days left
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- State governments
- Public & Indian housing authorities
- Tribal organizations
- Small businesses
- City & township governments
- Tribal governments
- For-profit businesses
- Nonprofits without 501(c)(3) status
Geography
- Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Overview
Exploratory Clinical Neuroscience Research on Substance Use Disorders
This Notice of Funding Opportunity (NOFO) uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying SUD, including fundamental brain function relevant to substance use. This NOFO is particularly designed to support exploratory/developmental projects requiring budgets that would exceed that allowed for the R21 mechanism (Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional)
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: PAR-26-093
- Expected Awards: 6
- Instrument: grant
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Focus Areas & Funding Uses
Fields of Work
- Addiction recovery
- Mental health
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Renewal of the Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $1.5M
Deadline
September 29, 2026
NIDCD's Mentored Research Education Pathway for Otolaryngology Residents and Medical Students (R25 - Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $499,999
Deadline
September 29, 2026
Cooperative Centers for Experimental Hematology (CCEHs) (U54- Clinical Trial Not Allowed)
National Institutes of Health
Amount
$3,745,000 total
Deadline
September 30, 2026
Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $3,300,000
Deadline
September 30, 2026
Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$3,000,000 total
Deadline
September 30, 2026
Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$2,000,000 total
Deadline
September 30, 2026
Ready to apply for Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional). Now let's win it.